Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Jorg Dietrich, M.D.,Ph.D.

TitleAssistant Professor of Neurology
InstitutionMassachusetts General Hospital
DepartmentNeurology
AddressMassachusetts General Hospital
MGH Cancer Center-Suite 9E
55 Fruit St
Boston MA 02114
Phone617/724-8770
Fax617/724-8769

 Mentoring 
 completed student projects
Neuroimaging Markers of Treatment-Associated Neurotoxicity in Glioblastoma Patients Undergoing Brain Radiation and Temozolomide Chemotherapy
Summer, 06/11/12 - 08/03/12

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen BR, Loeffler JS, Wen PY, Sorensen AG, Jain RK. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):19059-64.
    View in: PubMed
  2. Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Davidson C, Huang Y, Riedemann L, Taylor J, Ivy P, Duda DG, Ancukiewicz M, Plotkin SR, Chi AS, Gerstner ER, Eichler AF, Dietrich J, Stemmer-Rachamimov AO, Batchelor TT, Jain RK. Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma. Neuro Oncol. 2013 Aug; 15(8):1079-87.
    View in: PubMed
  3. Arrillaga-Romany IC, Dietrich J. Imaging findings in cancer therapy-associated neurotoxicity. Semin Neurol. 2012 Sep; 32(4):476-86.
    View in: PubMed
  4. Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol. 2012 Dec 11; 10(1):14-26.
    View in: PubMed
  5. Quant E, Dietrich J, Wen PY. Chemotherapy associated nervous system toxicity. Medlink Neurology, www.medlink.com. 2010.
  6. Dietrich J, Diamond EL, Kesari S. Glioma stem cell signaling: therapeutic opportunities and challenges. Expert Rev Anticancer Ther. 2010 May; 10(5):709-22.
    View in: PubMed
  7. Dietrich J. Chemotherapy associated central nervous system damage. Adv Exp Med Biol. 2010; 678:77-85.
    View in: PubMed
  8. Dietrich J. Chemotherapy associated central nervous system damage. Advances in Experimental Biology. 2010; in press.
  9. Dietrich J, Han R, Noble M, Yang M. Tamoxifen impairs neural progenitor cell function . Society for Neuro-Oncology, Annual Meeting, Montreal. 2010.
  10. Dietrich J, Hyrien O, Noble M. Quantitative analysis of the effects of chemotherapy on glial precursor cells. . Cancer Research. 2010; in press.
  11. Yang YM, Han R, Dietrich J, Noble M. CNS progenitor cells and oligodendrocytes are vulnerable to tamoxifen. Cancer Research. 2010; in press.
  12. Dietrich J, Diamond E, Kesari S. Glioma stem cell signaling: therapeutic opportunities and challenges. Expert Review Anticancer Therapy. 2010; 10(5):709-722.
  13. Dietrich J. Chemotherapy Associated Central Nervous System Damage. Chemobrain (Robert Raffa, ed). 2010.
  14. Dietrich J, D Wang, T Batchelor. Cediranib (Recentin™) – Profile of a novel anti-angiogenic agent in patients with malignant glioma. Expert Opinion on Investigational Drugs. 2009; 18(10):1-9.
  15. Dietrich J and Wen PY. Chemotherapy associated nervous system toxicity. Medlink Neurology. 2009; www.medlink.com.
  16. Dietrich J and Proschel C. Role of astrocyte biology in white matter disease. Leukodystrophies (Moser, Naidu, Raymond & Eichler, eds.). 2009.
  17. Dietrich J and Kesari S. Effect of cancer treatment on neural stem and progenitor cells. Cancer Treat Res. 2009; 150:81-95.
  18. Dietrich J, Kesari S. Effect of cancer treatment on neural stem and progenitor cells. Cancer Treat Res. 2009; 150:81-95.
    View in: PubMed
  19. Dietrich J, Norden AD, Wen PY. Emerging antiangiogenic treatments for gliomas - efficacy and safety issues. Curr Opin Neurol. 2008 Dec; 21(6):736-44.
    View in: PubMed
  20. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008 Dec; 13(12):1285-95.
    View in: PubMed
  21. Dietrich J, Monje M, Wefel J, Meyers CM. Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy. The Oncologist. 2008; 13(12):1-13.
  22. Dietrich J, Imitola J, Kesari S. Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas. Nat Clin Pract Oncol. 2008 Jul; 5(7):393-404.
    View in: PubMed
  23. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol. 2008; 7(4):12.
    View in: PubMed
  24. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, and Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the CNS. Journal of Biology. 2008; 7(4):12-24.
  25. Dietrich J, Norden A, Wen PY. Emerging anti-angiogenic treatments for gliomas: Efficacy and safety issues . Current Opinion in Neurology. 2008; 21(6):736-748.
  26. Dietrich J. Late Effects of Treatment for Brain Tumors. Effect of Cancer Treatment on Neural Stem Cells (Christopher Turner and Stewart Goldman - Editors). 2008.
  27. Dietrich J, and P Wen. Neurologic complications of chemotherapy. Cancer Neurology in Clinical Practice. (David Schiff, Patrick Wen, and Santosh Kesari - Editors). 2008.
  28. Dietrich J and Wen PY. Neurologic complications of chemotherapy. Cancer Neurology in Clinical Practice. (Schiff, Wen, Kesari - Editors). 2008.
  29. Dietrich J, Imitola J., and Kesari S. Mechanisms of Disease: Neural Stem Cells and Gliomas. Nature Clinical Practice Oncology. 2008; 5(7):393-404.
  30. Dietrich J and Wen P. Neurological complications of chemotherapy. MedLink Neurology. 2008; www.medlink.com.
  31. Dietrich J. Effect of Cancer Treatment on Neural Stem Cells. Late Effects of Treatment for Brain Tumors (C Turner and S Goldman - Editors). 2008.
  32. Valaikiene J, Schuierer G, Ziemus B, Dietrich J, Bogdahn U, Schlachetzki F. Transcranial color-coded duplex sonography for detection of distal internal carotid artery stenosis. AJNR Am J Neuroradiol. 2008 Feb; 29(2):347-53.
    View in: PubMed
  33. J Dietrich, Ruolan Han, Miranda Yang, and Mark Noble. Neural Progenitor Cells and Oligodendrocytes Are Highly Sensitive to Chemotherapy. Neurology 68(12). 2007; 68(12):289-290.
  34. Dietrich J, Chow MY, Phelan J, Nigwekar SU. Metastatic primary peritoneal carcinoma presenting as tension hydrothorax. Lancet Oncol. 2006 Sep; 7(9):784.
    View in: PubMed
  35. Dietrich J and Kempermann G. Role of endogenous neural stem cells in brain function, neurological disease, and brain repair. Brain Repair (Mathias Bahr, Editor). 2006; 191-220.
  36. Dietrich J, R Han, Y Yang, M Mayer-Pröschel, and M Noble. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology. 2006; 5(22).
  37. DJ Mock, P Chugh, B Kim, C Pröschel, J Dietrich, F Strathmann, B M Blumberg, and M Mayer-Pröschel. Characterization of specific HHV-6 and cell cycle genes implicated in virus-mediated G1/S cell-cycle arrest of glial precursors. Retrovirology 3(1). 2006; 3(1):22-23.
  38. Dietrich J, Chow MY, Phelan J, Nigwekar SU. Metastatic primary peritoneal carcinoma presenting as tension hydrothorax. Lancet Oncology. 2006; 7(9):784.
  39. Dietrich J, Kempermann G. Role of endogenous neural stem cells in neurological disease and brain repair. Adv Exp Med Biol. 2006; 557:191-220.
    View in: PubMed
  40. Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol. 2006; 5(7):22.
    View in: PubMed
  41. Dietrich J and Kempermann G. Role of endogenous neural stem cells in brain function, neurological disease, and brain repair. Advances in Exp Medicine and Biology. 2006; 557:191-204.
  42. Dietrich J, Lacagnina M, Gass D, Richfield E, Mayer-Pröschel M, Noble M, Torres C, Pröschel C. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med. 2005 Mar; 11(3):277-83.
    View in: PubMed
  43. Dietrich J, Noble M and Mayer-Proschel M. Human glial restricted precursor cells - isolation and propagation. 2005.
  44. Noble M and Dietrich J . Brain Tumors (Francis Ali-Osman, Editor). Analysis of neural precursor cells in the context of origin of brain tumors, their treatment, and repair of treatment-associated damage. 2005; 107-124.
  45. Dietrich J, M Lacagnina, D Gass, E Richfield, M Mayer-Pröschel, M Noble, C Torres, and C Pröschel. EIF2B5 mutations compromise generation of GFAP+ astrocytes from neural precursors in Vanishing White Matter leukodystrophy. Nature Medicine. 2005; 11(3):277-283.
  46. Dietrich J and Noble M. Caspase Inhibitors as Anticancer Agents. 2004.
  47. Dietrich J, Blumberg BM, Roshal M, Baker JV, Hurley SD, Mayer-Pröschel M, Mock DJ. Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J Neurosci. 2004 May 19; 24(20):4875-83.
    View in: PubMed
  48. Hau P, Fabel K, Baumgart U, Rümmele P, Grauer O, Bock A, Dietmaier C, Dietmaier W, Dietrich J, Dudel C, Hübner F, Jauch T, Drechsel E, Kleiter I, Wismeth C, Zellner A, Brawanski A, Steinbrecher A, Marienhagen J, Bogdahn U. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer. 2004 Mar 15; 100(6):1199-207.
    View in: PubMed
  49. Noble M, Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci. 2004 Mar; 27(3):148-54.
    View in: PubMed
  50. Maragakis NJ, Dietrich J, Wong V, Xue H, Mayer-Proschel M, Rao MS, Rothstein JD. Glutamate transporter expression and function in human glial progenitors. Glia. 2004 Jan 15; 45(2):133-43.
    View in: PubMed
  51. Hau P, Fabel K, Baumgart U, Ruemmele P, Grauer O, Bock A, Dietmaier W, Dietrich J et al. Pegylated Liposomal Doxorubicine – Efficacy in Patients with Recurrent High-Grade Glioma. Cancer. 2004; 15(6):1199-1207.
  52. J. Dietrich, B. M. Blumberg, M. Roshal, J. V. Baker, S. D.Hurley, M. Mayer-Pröschel, and D. J. Mock. Human Herpesvirus 6 increases oligodendrocyte differentiation from oligodendrocyte progenitor cells. Journal of Neuro-Virology 10. 2004; 10.
  53. Noble M and Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends in Neuroscience. 2004; 27(3):101-107.
  54. Dietrich J, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel and DJ Mock. Infection with an Endemic Human Herpesvirus Disrupts Critical Glial Precursor Cell Properties. Journal of Neuroscience. 2004; 24(20):4875-4883.
  55. Dietrich J, J Marienhagen, B Schalke, U Bogdahn and F Schlachetzki. Neurovascular toxicity following chemotherapy with cisplatin, etoposide and ifosfamide. Annals of Pharmacotherapy. 2004; 38:242-246.
  56. Dietrich J, J Marienhagen, B Schalke, U Bogdahn and F Schlachetzki. Neurovascular toxicity following chemotherapy with cisplatin, etoposide and ifosfamide. Annals of Pharmacotherapy. 2004; 38:242-246.
  57. AH Moore, M Noble, MK O’Banion and J Dietrich. Evaluation of cell proliferation, apoptosis and gliosis following neonatal brain irradiation. Proceedings of the Society for Neuroscience. 2004; 30:940.12.
  58. J Dietrich, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel and DJ Mock . Infection of human glial precursor cells induces G1/S cell-cycle arrest and alteration of critical cell functions related to activation of DNA damage mechanisms. . Journal of Neurovirology. 2004.
  59. Maragakis NJ, J Dietrich, V Wong, H Xue, M Mayer-Proschel, MS Rao, JD Rothstein. Glutamate transporter expression in human glial progenitors. Glia. 2004; 45(2):133-143.
  60. Dietrich J, Marienhagen J, Schalke B, Bogdahn U, Schlachetzki F. Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide. Ann Pharmacother. 2004 Feb; 38(2):242-6.
    View in: PubMed
  61. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M, Allgäuer M, Schuierer G, Koch H, Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A. Salvage therapy in patients with glioblastoma: is there any benefit? Cancer. 2003 Dec 15; 98(12):2678-86.
    View in: PubMed
  62. C Pröschel, J Dietrich, M Lacagninga, D Gass, E Richfield, M Noble, M Mayer-Pröschel. Analysis of glial lineage cells derived from a CACH/VWM leukodystrophy patient. Proceedings of the Society for Neuroscience 29. 2003; 29.
  63. J Dietrich, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel, and DJ Mock . Human Herpesvirus 6 Impairs Division and Alters Differentiation of Human Glial Precursors. Journal of Neuro-Virology 9(3). 2003; 9(3):33.
  64. J Dietrich and M Noble. Long-term impairment of cell proliferation and increased cell death in the adult CNS after chemotherapy. Proceedings of the American Association for Cancer Research (AACR). 2003; 44.
  65. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J et al. Salvage Therapy in Patients with Glioblastoma - is there any benefit?. Cancer. 2003; 98(12):2678-2686.
  66. J Dietrich, JV Baker, SD Hurley, B Blumberg, M Mayer-Proschel and DJ Mock . Effects of human herpesvirus type 6 (HHV-6) on cell proliferation and differentiation in human glial precursor cells. Proceedings of the Society for Neuroscience 29. 2003; 29.
  67. Dietrich J, Noble M, Mayer-Proschel M. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 2002 Oct; 40(1):65-77.
    View in: PubMed
  68. Dietrich J, Easterday MC. Developing concepts in neural stem cells. Trends Neurosci. 2002 Mar; 25(3):129-31.
    View in: PubMed
  69. Noble M, Dietrich J. Intersections between neurobiology and oncology: tumor origin, treatment and repair of treatment-associated damage. Trends Neurosci. 2002 Feb; 25(2):103-7.
    View in: PubMed
  70. Dietrich J, M Noble and M Mayer-Proschel . Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 2002; 40(1):65-77.
  71. P Hau, J Dietrich, K Fabel, U Baumgart, O Grauer et al. Liposomal doxorubicin with and without tamoxifen in the salvage treatment of high grade glioma – a phase II study. Proceedings of the American Society of Clinical Oncology (ASCO) 38. 2002; 38:312.
  72. Dietrich J and MC Easterday. Developing Concepts in Neural Stem Cells. Trends in Neuroscience. 2002; 25(3):129-131.
  73. P Hau, J Dietrich, K Fabel and U Bogdahn. Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin. Expert Reviews in Neurotherapeutics. 2002; 2(5):89-96.
  74. NJ Maragakis, V Wong, H Xue, MS Rao, J Dietrich, M Mayer-Proschel, JD Rothstein. Glutamate transporter expression and function in human glial progenitors. Proceedings of the Society for Neuroscience 28. 2002; 28:424.9.
  75. J Dietrich, M Noble and M Mayer-Proschel. In vitro characterization of human glial restricted precursor cells. Faseb Journal 16(5). 2002; 16(5):1112.
  76. M Noble and J Dietrich. Intersections between neurobiology and oncology: tumor origin, tumor treatment and repair of treatment associated damage. Trends in Neuroscience. 2002; 25(2):103-107.
  77. Fabel K, Dietrich J, Hau P, Wismeth C, Winner B, Przywara S, Steinbrecher A, Ullrich W, Bogdahn U. Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer. 2001 Oct 1; 92(7):1936-42.
    View in: PubMed
  78. K Fabel, J Dietrich, P Hau et al. Recurrent High-Grade Glioma: Stabilization After Treatment with Pegylated Doxorubicin in Combination with Tamoxifen – a phase II clinical trial. Proceedings of the American Society of Clinical Oncology (ASCO) 37. 2001; 37:2049.
  79. Dietrich J, Hau P, Fabel K, Baumgart U, Jauch T, Moriabadi N, Zellner A, Steinbrecher A, Bogdahn U . Phase-II Studie bei hochmalignen Gliomen: Stabilisierung unter Therapie mit liposomal verkapseltem Doxorubicin. Aktuelle Neurologie 35. 2001; 35:211.
  80. J Dietrich, Hau P, Fabel K, Zellner A, Steinbrecher A, Ullrich W, and Bogdahn U. Phase II Clinical Trial in High-Grade Glioma: Stabilization of Disease in Patients treated with Liposomal Doxorubicin. Proceedings of the American Society of Clinical Oncology (ASCO) 37. 2001; 37:262.
  81. J Dietrich, DJ Messina, PA Tresco, M Noble, M Mayer-Proschel. Characterization of human glia restricted precursor (hGRP) cells in vitro and after transplantation into the adult mammalian brain. Proceedings of the Society for Neuroscience 27. 2001; 27(2):37.
  82. J Dietrich, M Mayer-Proeschel, M Noble. Chemosensitivity of Glia and Glia Precursor Cells. Proceedings of the American Association for Cancer Research (AACR) 42. 2001; 42:553-554.
  83. Fabel K, Hau P, Dietrich J, Baumgart U, Jauch T, Moriabadi N, Zellner A, Steinbrecher A, Bogdahn U. 13-cis-Retinsaeure in der Erhaltungstherapie bei makroskopisch tumorfreien Patienten mit hochmalignem Gliom nach Abschluss der Primaertherapie. Aktuelle Neurologie 35. 2001; 35:121.
  84. Aigner L, Fluegel D, Dietrich J, Ploetz S, Winkler J. Isolated lissencephaly sequence and double-cortex syndrome in a German family with a novel doublecortin mutation. Neuropediatrics. 2000 Aug; 31(4):195-8.
    View in: PubMed
  85. K Fabel-Schulte, P Hau, J Dietrich, C Wismeth, M Angerer, A Steinbrecher, R Apfel, A Brawanski, U Bogdahn. 13-cis-retinoic acid as a potential treatment in glioma patients who show stable disesase after combined modality treatment. Proceedings of the American Society of Clinical Oncology (ASCO) 36. 2000; 36:662.
  86. J Dietrich, P Hau, K Fabel-Schulte, C Wismeth, M Angerer, A Steinbrecher, W Ulrich, A Brawanski, U Bogdahn. Liposomal doxorubicin (Caelyx‚) in the treatment of recurrent high-grade glioma – a phase I/II study. Proceedings of the American Society of Clinical Oncology (ASCO) 36. 2000; 36:661.
  87. Fabel-Schulte K, Dietrich J, Hau P, Wismeth C, Angerer M, Bogdahn U. Phase I/II pilot study of liposomal doxorubicin (Caelyx‚) in the treatment of recurrent high-grade gliomas. Proceedings of the American Association for Cancer Research (AACR) 41. 2000; 41:1644.
  88. Dietrich J und Bogdahn U. Standard therapy and novel treatment concepts of malignant gliomas. Onkologie. 1999; 3-7.
  89. Dietrich J, Angerer M, Bodenteich A, Ullrich H, Schlachetzki F, Bogdahn U, Drlicek M . Paraneoplastic cerebellar degeneration with severe ataxia in a patient with anti-Yo antibodies: clinical presentation and treatment. Neuropsychiatrie. 1999; 13(1):2.
  90. P Hau, J Dietrich, U Bogdahn. Therapy of malignant gliomas. Onkologie. 1999; 11:34-35.
  91. Dietrich J, Aigner L, Flügel D, Plötz S, Winkler J. A novel mutation in the doublecortin gene in a family with Doublecortex syndrome and Lissencephaly. Aktuelle Neurologie 26. 1999; 26(1):77-78.
  92. Dietrich J, Sachsenheimer W, Kempermann G, Bach A, Bogdahn U. Decreased expression of VEGF receptor flt-1 in malignant gliomas — semiquantitative analysis of flt-1 mRNA expression in brain tumors using Lamin B as internal standard. Proceedings of the American Association for Cancer Research (AACR) 40. 1999; 40:1512.
  93. C Framme, J Dietrich, CP Lohmann, HG Sachs. Eye involvement in circumscript cutaneous sclerosis - a manifestation of borreliosis?. Klinisches Monatsblatt fur Augenheilkunde. 1999; 215:258-262.
  94. Dietrich J, Angerer M, Bodenteich A, Ullrich H, Schlachetzki F, Bogdahn U, Drlicek M. Paraneoplastic cerebellar degeneration with severe ataxia in a patient with anti-Yo antibodies: clinical presentation and treatment. Neuropsychiatrie 13. 1999; 13(1):2.
  95. Dietrich J. Expression analysis of the neurotransmitter receptors for dopamine and serotonin, and of the growth factor receptors for Endothelin A, Endothelin B, and VEGF in Human Brain Tumors and Normal Human Brain. 1998.
  96. J Dietrich, G Kempermann, W Sachsenheimer, A Bach, K Fabel-Schulte, U Bogdahn. Expression of endothelin receptors in brain tumors. Journal of Neuro-Oncology 39. 1998; 39(2):269.
  97. F Schlachetzki, T Hoelscher, B Götz, J Dietrich, U Bogdahn. Three dimensional transcranial color-coded duplex sonography - a new perspective?. Aktuelle Neurologie 25. 1998; 25:150.
  98. Dietrich J, Kempermann G, Sachsenheimer W, Bach A, Bogdahn U. Semiquantitative analysis of dopamine receptor expression in human brain tumors. Proceedings of the American Association for Cancer Research (AACR) 39. 1998; 39:2409.
  99. J Dietrich, I Trender, F Schlachetzki, M Angerer, U Bogdahn. Stiff-Person-Like Syndrome in Addison’s Disease. Movement Disorders 13. 1998; 13(2):207.
  100. J Dietrich, I Trender, F Schlachetzki, M Angerer, U Bogdahn . Stiff-Person-Like Syndrome in Addison’s Disease. Movement Disorders. 1998; 13(2):207.
  101. F Schlachetzki, T Hoelscher, J Dietrich, U Bogdahn . Persistent trigeminal artery associated with occlusion of the left internal carotid artery. Annals of Neurology 44. 1998; 44(3):113.
  102. F Schlachetzki, T Hoelscher, J Dietrich, U Bogdahn . Persistent trigeminal artery associated with occlusion of the left internal carotid artery. Annals of Neurology. 1998; 44(3):113.
  103. J Dietrich, G Kempermann, HG Kuhn, W Sachsenheimer, A Bach, U Bogdahn. Semiquantitative analysis of VEGF receptor expression in gliomas and normal cortex. Proceedings of the Society for Neuroscience 23. 1997; 23(2445).
  104. Gaiger A, Lion T, Födinger M, Dietrich J, Wolz M, Sillaber C, Henn T, Korninger L, Schwarzinger I, Mitterbauer G, Kyrle P A, Lechner K. Cytogenetic and moleculargenetic analyses in a patient with M-BCR rearranged Philadelphia positive AML. Annals of Hematology 67. 1993; 67:36.
  105. Gaiger A, T Lion, P Kahls, T Henn, J Dietrich, H Greinix, K Feil, K Geissler, K Lechner . Moleculargenetic analyses in patients with chronic myeloid leukemia: Increase of specific mRNA expression during progression to blast crisis. Annals of Hematology 67. 1993; 67:36.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Dietrich's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_